Jitao Y. Wu

NO. 20 East Yuhuangding Road
Yantai, 264000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 217 publications

POU2F2 as a dual oncogenic and immunomodulatory driver in kidney renal clear cell carcinoma.

POU2F2 as a dual oncogenic and immunomodulatory driver in kidney renal clear cell carcinoma.

Journal: Cell adhesion & migration

Published: July 09, 2026

Corrigendum to "Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment" [Clinical Genitourinary Cancer 22/2 (2024) 569-579.e1].

Corrigendum to "Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment" [Clinical Genitourinary Cancer 22/2 (2024) 569-579.e1].

Journal: Clinical genitourinary cancer

Published: June 04, 2026

Comment on "Analysis of risk factors and development of a prediction model for acute kidney injury in elderly patients after abdominal surgery".

Comment on "Analysis of risk factors and development of a prediction model for acute kidney injury in elderly patients after abdominal surgery".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: May 30, 2026

Integrative multi-omics identifies PANX2 as a ferroptosis suppressor and potential therapeutic target in clear cell renal cell carcinoma.

Integrative multi-omics identifies PANX2 as a ferroptosis suppressor and potential therapeutic target in clear cell renal cell carcinoma.

Journal: Frontiers in immunology

Published: May 17, 2026

Dietary Guidelines for 2025-2030.

Dietary Guidelines for 2025-2030.

Journal: JAMA

Published: April 30, 2026

Exploring the mechanism by which triphenyl phosphate promotes malignant phenotypes in bladder and kidney cancer through MMP9 based on bioinformatics analysis and experimental validation.

Exploring the mechanism by which triphenyl phosphate promotes malignant phenotypes in bladder and kidney cancer through MMP9 based on bioinformatics analysis and experimental validation.

Journal: Clinical and experimental medicine

Published: April 06, 2026

Re: Khan S, Papa N, Kneebone A, et al. Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol. 2026;89:512-520.

Re: Khan S, Papa N, Kneebone A, et al. Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol. 2026;89:512-520.

Journal: European urology

Published: April 04, 2026

Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making.

Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making.

Journal: Frontiers in oncology

Published: March 25, 2026

Robot-assisted third kidney transplantation in a patient with exhausted iliac fossae: A case report.

Robot-assisted third kidney transplantation in a patient with exhausted iliac fossae: A case report.

Journal: Therapeutic advances in urology

Published: March 06, 2026

Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma.

Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma.

Journal: BMC cancer

Published: February 24, 2026

EPB41L family serves as a prognostic biomarker for kidney renal clear cell carcinoma.

EPB41L family serves as a prognostic biomarker for kidney renal clear cell carcinoma.

Journal: Cell adhesion & migration

Published: February 04, 2026

A deep learning-based multimodal model with automated body composition analysis predicts prognosis in advanced clear cell renal cell carcinoma.

A deep learning-based multimodal model with automated body composition analysis predicts prognosis in advanced clear cell renal cell carcinoma.

Journal: Scientific reports

Published: January 19, 2026

Showing 1-12 of 217

Last Updated: 09/26/2026